6-Bromo-4-chlorothieno[2,3-d]pyrimidin-2-amine

Catalog No.: 
ACFTIN003
CAS No.: 
1160994-64-8
Molecular Formula: 
C6H3BrClN3S
Molecular Weight: 
264.54
6-Bromo-4-chlorothieno[2,3-d]pyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-4-chlorothieno[2,3-d]pyrimidin-2-amine
IUPAC Name6-bromo-4-chlorothieno[2,3-d]pyrimidin-2-amine
Molecular FormulaC6H3BrClN3S
Molecular Weight264.54
SMILESNC1=NC(Cl)=C(C=C(Br)S2)C2=N1
InChI KeyWEIDOVKLKZXISY-UHFFFAOYSA-N
Synonym6-BroMo-4-chlorothieno[2,3-d]pyriMidin-2-aMine;Thieno[2,3-d]pyrimidin-2-amine, 6-bromo-4-chloro-
CAS No.1160994-64-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFTIN003 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACFTIN003 route product structure diagram
    ACFTIN0031160994-64-8
Inquiry

2. ACFTIN003 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5In Stock
  4. Then
  5. ACFTIN003 route product structure diagram
    ACFTIN0031160994-64-8
Inquiry

3. ACFTIN003 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFTIN003 route product structure diagram
    ACFTIN0031160994-64-8
Inquiry

Comments (0)